Stryker Stock News

The Nerve Conduit Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an

Competitors are starting to appear, but they're still years behind.

Ardevora Asset Management LLP lowered its holdings in Stryker Co. (NYSE:SYK) by 2.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 269,583 shares of the medical technology companys stock after selling 7,600 shares during the period. Ardevora Asset Management LLP owned approximately 0.07% of Stryker worth []

Canton Hathaway LLC purchased a new stake in shares of Stryker Co. (NYSE:SYK) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 115 shares of the medical technology companys stock, valued at approximately $30,000. Several other institutional investors and hedge funds []

Stryker Co. (NYSE:SYK) saw some unusual options trading activity on Friday. Traders purchased 3,612 put options on the company. This represents an increase of 220% compared to the typical daily volume of 1,130 put options. A number of equities analysts recently weighed in on SYK shares. SVB Leerink restated an outperform rating on shares of []

Scharf Investments LLC grew its position in shares of Stryker Co. (NYSE:SYK) by 21.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,768 shares of the medical technology companys stock after buying an additional 1,021 shares during the quarter. Scharf Investments []

Becker Capital Management Inc. lifted its position in shares of Stryker Co. (NYSE:SYK) by 3.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 4,187 shares of the medical technology company’s stock after acquiring an additional 123 shares during the period. Becker Capital Management Inc.’s holdings in Stryker were worth $1,104,000 as of its most […]

Key Players covered in the Knee Replacement Market Research Report are Zimmer Biomet (Indiana, U.S.), Stryker (Michigan, U.S.), DePuySynthes Companies (Johnson & Johnson Services, Inc.) (Indiana, U.S.), Smith & Nephew (London, U.K.), Aesculap, Inc. a B. Braun company (Center Vally, USA), Medacta International (Castel San Pietro, Switzerland), MicroPort Scientific Corporation (Shanghai, China), Conformis (Massachusetts, U.S.), Other Prominent Players. Key Players covered in the Knee Replacement Market Research Report are Zimmer Biomet (Indiana, U.S.), Stryker (Michigan, U.S.), DePuySynthes Companies (Johnson & Johnson Services, Inc.) (Indiana, U.S.), Smith & Nephew (London, U.K.), Aesculap, Inc. a B. Braun company (Center Vally, USA), Medacta International (Castel San Pietro, Switzerland), MicroPort Scientific Corporation (Shanghai, China), Conformis (Massachusetts, U.S.), Other Prominent Players.

Global Laparoscopic Instruments Market Overview: The Global Laparoscopic Instruments Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players. It

Global Fine Needle Aspiration Market Synopsis: The large scale Fine Needle Aspiration Market report sheds light on each region, Market size in terms of (USD Mn) for every individual segment and their sub-segment for the period from 2021 to 2028, considering

Neurovascular intervention is the use of minimally invasive medical devices and techniques to treat vascular diseases of central nervous system. Neurovascular interventional procedures help to avoid surgeries of high-risk zones of body such as brain, spine, or the neck. The Global

The reliable Hospital Furniture market report performs thorough analysis of the potential of the market in the present and the future prospects from various angles. The report provides segmentation of the global market on the basis of technology, application, product,

Security National Bank raised its position in Stryker Co. (NYSE:SYK) by 5.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 26,771 shares of the medical technology company’s stock after acquiring an additional 1,392 shares during the period. Stryker accounts for about 1.8% of Security National Bank’s portfolio, making the stock its 24th largest position. […]

Veracity Capital LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 19.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 989 shares of the medical technology companys stock after purchasing an additional 163 shares during the quarter. Veracity Capital LLCs holdings in []

Market participants should invest more in research and development to help the market flourish. The market''s major players are concentrating their efforts on research and development in order to provide novel solutions that answer patients'' crucial unmet requirements. For example,